SK Capital Partners is entering exclusive negotiations to acquire the Medical division of LISI Group, a leading CDMO in the MedTech industry.

Target Information

SK Capital Partners, a private investment firm based in New York, is in exclusive negotiations to acquire the Medical division of LISI Group. LISI Medical is recognized as a prominent Contract Development and Manufacturing Organization (CDMO) within the MedTech sector, specializing in the production of high-precision metal components and assemblies. These products cater to global original equipment manufacturers (OEMs) in the medical device industry.

Industry Overview

The MedTech industry has been experiencing substantial growth across various countries, driven by advancements in technology and an increasing demand for innovative medical devices. In particular, the presence of dedicated CDMOs has become pivotal, as they offer specialized manufacturing services that help medical device companies accelerate their product development while ensuring compliance with stringent regulatory requirements.

In countries like the United States and those within the European Union, the market is supported by a robust healthcare system, which encourages investment in medical technologies. Regulatory bodies facilitate a stru